Patients with diabetes advised to take extra care in summer holiday heat

Patients with diabetes are being advised to take precautions during hot weather if they are enjoying the sun at home or during the summer holiday overseas.

Many of the favourite holiday hotspots in Europe are currently experiencing a heatwave, with temperatures likely to stay warm in the UK too.

Around six per cent of the population of Staffordshire and Stoke-on-Trent has a diagnosis of type 2 diabetes, the most common kind, and the number is growing year-on-year.

Hot weather can affect diabetes control and make blood sugar levels higher than normal.

Just one way to follow NHS commissioners on Twitter in Staffordshire and Stoke-on-Trent

Social media users now have a new way of finding out about the latest news and information from NHS commissioners across Staffordshire and Stoke-on-Trent.

A new Twitter account - @StaffsCCGs – will combine news and information from the area’s six clinical commissioning groups (CCGs). Previously the CCGs had separate accounts.

Sue Harper, Chair of the CCG’s Communications and Engagement Committee and Lay Member for Patient and Public Involvement with Stafford and Surrounds CCG said: “Last year the six CCGs agreed that we would collaborate more closely in the interests of improving services for our patients.

NHS England consults public about Evidence-Based Interventions

People are being asked for their views about plans to stop offering treatments that are clinically ineffective.   

NHS England is proposing that the following interventions should no longer be routinely commissioned by CCGs because they are ineffective or have been superseded by a safer alternative:

  • Snoring Surgery (in the absence of Obstructive Sleep Apnoea)
  • Dilatation and curettage for heavy menstrual bleeding in women
  • Knee arthroscopy for patients with osteoarthritis
  • Injections for nonspecific low back pain without sciatica

They are also recommending that thirteen other interventions should only be performed in specific circumstances where they have been proved to be clinically effective.

For more information and to respond, please visit:

The deadline for responding is Friday 28 September 2018.

We use cookies to improve your experience of using this website. how we use cookies